Johnson & Johnson damages cut in half in talcum powder cancer suit
By Alen A Missouri appeals court on Tuesday reduced a damages award against Johnson & Johnson to about $2.12 billion from $4.69 billion in a case brought by 22 women …
Read MoreTag: cancer
Shares of cancer treatment company ArQule surge 100 percent on Merck acquisition
By Morgan Drug giant Merck & Co. agreed Monday to acquire ArQule, a cancer-treating biopharmaceutical company, for $20 per share in cash for a total equity value of around $2.7 …
Read More